THERE'S AN ALTERNATIVE TO WARFARIN
FOR PEOPLE WHO NEED ONE. IT'S CALLED WATCHMAN™.
A one-time procedure that effectively reduces the risk of stroke in patients with non-valvular atrial fibrillation.See How It Works
Explore our breakthrough products that make a meaningful difference in patient's lives.
Discover our reimbursement resources including coding guides and our c-code lookup tool.
Learn about living with an implanted device, explore health conditions and treatment options, and get support.
Boston Scientific Announces Positive Outcomes From Prospective Study Of Bronchial Thermoplasty
The Boston Scientific LOTUS™ Valve System Demonstrated Superior Efficacy to CoreValve® in Global REPRISE III Trial at One Year
Boston Scientific Closes Symetis Acquisition
Boston Scientific Announces Positive European Registry Results For WATCHMAN™ Left Atrial Appendage Closure Device
New Data from PLATINUM Diversity Study Presented at SCAI 2017 Provide Important Insights Beyond Traditional Clinically-Reported Endpoints
Boston Scientific S-ICD System Demonstrates Positive Clinical Outcomes in the Largest Prospective Study of 'Real-World' Patients
Boston Scientific Announces Schedule of Presentations at EuroPCR 2017
Boston Scientific Receives U.S. FDA Approval For Resonate™ Family Of High-Voltage Devices
Boston Scientific Announces Results For First Quarter 2017